His work has primarily utilized epidemiologic methods and clinical trials to understand disease patterns that overlap between kidney and vascular disease, and to test novel therapies to improve vascular disease in the kidney patient. He is particularly interested in the effects of blood pressure control on kidney disease and its complications and is a principal investigator of an NIH award focused on this topic. He also served as the San Diego Site principal investigator and a member of the CKD working group within the SPRINT trial. Dr. Ix has co-authored over 370 peer-reviewed scienti c papers, has previously served as an associate editor for the Journal of the American Society of Nephrology and Circulation. biographic and disclosure information www.kidney-international.org In 2020, he received the Shaul G. Massry Award from the US National Kidney Foundation. Consultancy: AstraZeneca and Sani t Grants/research support: Baxter International* and National Institutes of Diabetes and Digestive and Kidney Diseases* Travel expenses: American Society of Nephrology and Insti- tute of Medicine *Monies paid to institution. Gregory A. Knoll, MD, MSc, FRCPC, is head of the Division of Nephrology at the Ottawa Hospital and a professor of medicine at the University of Ottawa, Canada. He currently holds the University of Ottawa Chair in Clinical Transplantation Research and is a senior scientist with the Clinical Epidemiology Program of the Ottawa Hospital Research Institute. He completed his nephrology fellowship at the University of Ottawa, followed by a kidney transplant fellowship at the University of Alabama at Bir- mingham, USA. Following this training, he took further graduate work and received a master s degree in epidemi- ology. For over 15 years, he was the medical director of kidney transplantation at the Ottawa Hospital. He assumed his cur- rent position as head of the nephrology division in 2016. 